2021
DOI: 10.1186/s12859-021-04457-1
|View full text |Cite
|
Sign up to set email alerts
|

SVDNVLDA: predicting lncRNA-disease associations by Singular Value Decomposition and node2vec

Abstract: Background Numerous studies on discovering the roles of long non-coding RNAs (lncRNAs) in the occurrence, development and prognosis progresses of various human diseases have drawn substantial attentions. Since only a tiny portion of lncRNA-disease associations have been properly annotated, an increasing number of computational methods have been proposed for predicting potential lncRNA-disease associations. However, traditional predicting models lack the ability to precisely extract features of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 72 publications
(43 reference statements)
0
8
0
Order By: Relevance
“…In order to evaluate the robustness of GATMDA, we further test the performance of GATMDA on another dataset named HMDD v3.2 [ 43 ]. We obtain the dataset of HMDD v3.2 from Li’s model [ 44 ], which includes 4189 interactions between 437 miRNAs and 431 diseases, 8172 relationships between 861 lncRNAs and 437 miRNAs, and 4518 lncRNA-disease correlations. To obtain a systematic and convincing comparison, we compare GATMDA method with several baselines on HMDD v3.2, including LAGCN [ 39 ], NEMII [ 22 ] and GCAEMDA [ 45 ].…”
Section: Resultsmentioning
confidence: 99%
“…In order to evaluate the robustness of GATMDA, we further test the performance of GATMDA on another dataset named HMDD v3.2 [ 43 ]. We obtain the dataset of HMDD v3.2 from Li’s model [ 44 ], which includes 4189 interactions between 437 miRNAs and 431 diseases, 8172 relationships between 861 lncRNAs and 437 miRNAs, and 4518 lncRNA-disease correlations. To obtain a systematic and convincing comparison, we compare GATMDA method with several baselines on HMDD v3.2, including LAGCN [ 39 ], NEMII [ 22 ] and GCAEMDA [ 45 ].…”
Section: Resultsmentioning
confidence: 99%
“…While research exploring the application of these methods to biological networks is still in its early stages, there is considerable interest. These applications can be loosely divided into three categories; (1) drug-related applications , such as drug-target interactions (DTIs) (49), drug-disease interactions (1012), drug side-effects (13, 14), drug-drug interactions (1517), polypharmacy antagonistic effects (18, 19) and synergistic reactions in drug combination therapy (20); (2) protein-related applications , such as protein-protein interactions (PPIs) (2124) and protein/gene disease interactions (2531); and (3) transcriptomics-related applications , such as lncRNAs-diseases associations (3235) and miRNAdisease associations (3643) and many other applications (4450).…”
Section: Introductionmentioning
confidence: 99%
“…(2) protein-related applications, such as protein-protein interactions (PPIs) (21)(22)(23)(24) and protein/gene disease interactions (25)(26)(27)(28)(29)(30)(31); and (3) transcriptomics-related applications, such as lncRNAs-diseases associations (32)(33)(34)(35) and miRNAdisease associations (36)(37)(38)(39)(40)(41)(42)(43) and many other applications (44)(45)(46)(47)(48)(49)(50). Since network embedding methods were not originally developed for biological networks, their performance in obtaining different biological network features is yet to be established.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, to consider the global topological information, several studies have tried to use random walk with restart to capture the global topological information ( Valdeolivas et al, 2019 ). Furthermore, other network representation methods, like node2vec, are used to predict disease ( Li et al, 2021 ). However, these methods are not designed for predicting the miRNA associated with Multiple Sclerosis.…”
Section: Introductionmentioning
confidence: 99%